“Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome.”, J Clin Oncol, vol. 39, no. 30, pp. 3328-3339, 2021.
, “Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.”, Blood, vol. 138, no. 16, pp. 1429-1440, 2021.
,